Data / New clinical trials / Liver Neoplasms

Liver Neoplasms trials: 172 new since Nov 2024

Name: New Liver Neoplasms clinical trials
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New Liver Neoplasms clinical trials: 172 rows for $8.60, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 7 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/liver-neoplasms, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 5, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

172 clinical studies in Liver Neoplasms were first posted on ClinicalTrials.gov from November 14, 2024 to November 5, 2026; 27 have an industry sponsor and 138 are recruiting or about to. The newest, NCT07919717, was posted on November 5, 2026: NIVO+IPI Neoadjuvant Therapy for Recurrent Resectable HCC (Shanghai Zhongshan Hospital).

The request: Every new Liver Neoplasms clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

172New trials
27Industry sponsored
138Recruiting or not yet
November 5, 2026Latest posted

Newest trials

The newest 100 of 172, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
November 5, 2026	NCT07919717	NIVO+IPI Neoadjuvant Therapy for Recurrent Resectable HCC	Shanghai Zhongshan Hospital	Phase 2	Not yet recruiting	Hepatocellular Carcinoma (HCC), Recurrent Hepatocellular Cancer	35	China	clinicaltrials.gov
November 4, 2026	NCT07916376	Characterizing Tumor Hypoxia With BOLD-MRI to Predict Y-90 Treatment Response	UNC Lineberger Comprehensive Cancer Center	Not applicable	Not yet recruiting	Hepatocellular Carcinoma, Liver Cancer	12	United States	clinicaltrials.gov
November 3, 2026	NCT07911683	Study Evaluating the Efficacy and Safety of BGB-B2033 in Participants With Advanced Hepatocellular Carcinoma	BeOne Medicines	Phase 2	Not yet recruiting	Hepatocellular Cancer, Liver Cancer, Hepatocellular Carcinoma	100		clinicaltrials.gov
November 2, 2026	NCT07911267	Development and Utilization of an Integrated Clinical Genomic Database	Samsung Medical Center	Observational	Recruiting	Gastric Cancer, Colorectal Cancer, Lung Cancer (NSCLC), Liver Cancer, Pancreatic Cancer	118,750	South Korea	clinicaltrials.gov
October 29, 2026	NCT07904494	Immune-Related Adverse Events and Clinical Outcomes of First-Line Immunotherapy in Egyptian Patients With Unresectable Hepatocellular...	Assiut University	Observational	Not yet recruiting	Hepatocellular Carcinoma, Hepatocellular Carcinoma (HCC), Hepatocellular Carcinoma Non-Resectable, Hepatocellular...	294	Egypt	clinicaltrials.gov
October 28, 2026	NCT07900984	A Retrospective Registry of Intelliblate DUAL Channel Microwave Ablation	Varian, a Siemens Healthineers Company	Observational	Not yet recruiting	Liver Ablation, Liver Cancer, Liver Cancer (Primary and Metastatic)	63		clinicaltrials.gov
October 5, 2026	NCT07857317	Non-Contrast Versus Contrast-Enhanced MRI in Colorectal Liver Metastases	Assiut University	Observational	Not yet recruiting	Liver Metastases, Liver Neoplasms	40		clinicaltrials.gov
September 30, 2026	NCT07848750	InstaSure™ Non-Invasive Finger-Press Test for Hepatocellular Carcinoma	Beijing Municipal Administration of Hospitals	Observational	Recruiting	Hepatocellular Carcinoma	40	China	clinicaltrials.gov
September 23, 2026	NCT07836530	Study Comparing BGB-B2033 With Sorafenib or Lenvatinib in Relapsed Hepatocellular Carcinoma	BeOne Medicines	Phase 3	Not yet recruiting	Hepatocellular Carcinoma, Liver Cancer	492		clinicaltrials.gov
September 22, 2026	NCT07834268	Feasibility of Multi-cancer Early Detection Test in Screening Population (NQMD-CS)	Fifth Affiliated Hospital of Guangzhou Medical University	Not applicable	Active not recruiting	Colorectal Cancer, Grastic Cancer, Esophageal Cancer, Lung Cancer, Liver Cancer	1,250	China	clinicaltrials.gov
September 22, 2026	NCT07834125	Patients With Cryptogenic Hypertransaminasemia	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	Observational	Not yet recruiting	Cryptogenic Hypertransaminasemia	30	Italy	clinicaltrials.gov
September 22, 2026	NCT07832617	Protoacoustic Imaging For 3D Mapping	University of Oklahoma	Observational	Recruiting	Proton Therapy, Radiation Therapy, Secondary Skin Reactions, Liver Cancer, Prostate Cancer	24	United States	clinicaltrials.gov
September 21, 2026	NCT07830576	Multimodal Survival Prediction Model for Colorectal Liver Metastases Post-Operation	Anhui Provincial Hospital	Observational	Recruiting	Colorectal Liver Metastases, Colorectal Neoplasms, Liver Neoplasms	205	China	clinicaltrials.gov
September 17, 2026	NCT07824583	A Study Evaluating a New Radiation Treatment Workflow (NGDS)	Varian, a Siemens Healthineers Company	Not applicable	Recruiting	Lung Cancer (Diagnosis), Liver Cancer, Adult, Pancreatic Cancer, Thoracic Cancers, Abdominal Cancer	20	United States	clinicaltrials.gov
September 15, 2026	NCT07820644	A Cohort Study (Risk Prediction of HCC in Patients With Chronic Liver Disease)	Cai Qingxian	Observational	Recruiting	Liver Cancer (Primary and Metastatic)	15,000	China	clinicaltrials.gov
September 14, 2026	NCT07817147	CREO - Microwave Ablation Feasibility Study	Banner Health	Not applicable	Recruiting	Pancreatic Cancer, Liver Cancer (Locally Advanced or Metastatic), Pancreatic Cancer Non-resectable, Pancreatic Cancer...	75	United States	clinicaltrials.gov
September 10, 2026	NCT07811453	Liver Transplantation for Non-Resectable Colorectal Liver Metastases Without Local Treatment Options	Charite University, Berlin, Germany	Not applicable	Not yet recruiting	Colorectal Neoplasms, Liver Neoplasms, Neoplasm Metastases, Colorectal Liver Metastases, Metastatic Colorectal Cancer...	260	Germany	clinicaltrials.gov
August 28, 2026	NCT07793253	Phase 2 Study of Daraxonrasib in Recurrent KRAS-Mutant Biliary Tract Cancer	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Phase 2	Not yet recruiting	Biliary Tract Cancers, Intrahepatic Cholangiocarcinoma (Icc), Extrahepatic Cholangiocarcinoma, Gallbladder Carcinoma...	55	United States	clinicaltrials.gov
August 27, 2026	NCT07790419	A Prospective, Single-Arm, Open-Label Clinical Study of the Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Combined With...	Zhai Wenlong	Phase 4	Not yet recruiting	Liver Cancer	40	China	clinicaltrials.gov
August 24, 2026	NCT07781852	Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer	Lumina Pharmaceuticals Inc	Early phase 1	Not yet recruiting	Bladder Cancer, Glioma, Glioblastoma (GBM), Breast Cancer, Colorectal Cancer, Esophageal Cancer, Gastric Cancer (GC)...	40	United States	clinicaltrials.gov
August 14, 2026	NCT07764835	Prospective Evaluation of Hepatocellular Carcinoma Surveillance in At-Risk Patients (Screening HCC)	D'Or Institute for Research and Education	Observational	Not yet recruiting	Hepatocellular Carcinoma, Liver Cirrhosis, Chronic Hepatitis B, Metabolic Dysfunction-Associated Steatotic Liver...	300		clinicaltrials.gov
August 13, 2026	NCT07763301	YMN-136 Vaccine for Patients With Advanced Hepatobiliary and Pancreatic Malignancies	West China Hospital	Phase 1	Recruiting	Liver Cancer, Pancreatic Cancer, Biliary Tract Cancer (BTC)	9	China	clinicaltrials.gov
August 6, 2026	NCT07750275	Safety and Economics of Parenchymal Transection in Minimally Invasive Liver Surgery	University of Molise	Observational	Enrolling by invitation	Liver Surgery, MINIMALLY INVASIVE LIVER SURGERY, Liver Neoplasm	800	Italy	clinicaltrials.gov
August 4, 2026	NCT07745790	Safety and Efficacy of Multimodal Thermal Therapy (MTT) Combined With KRAS G12V mRNA Vaccine, S-1, and Sintilimab in Patients With...	Ruijin Hospital	Phase 2	Not yet recruiting	Pancreatic Ductal Adenocarcinoma, Liver Neoplasms, Lung Neoplasms	20	China	clinicaltrials.gov
August 4, 2026	NCT07745153	Novel Abdominal Compression Positioning Technique for Respiratory Motion Management in Liver Tumors	Southern Medical University, China	Observational	Completed	Liver Neoplasms, Carcinoma, Hepatocellular	120	China	clinicaltrials.gov
August 3, 2026	NCT07741903	Development of a Risk Prediction Model for Immune-Targeted Therapy-Related Diarrhea in Patients With Hepatocellular Carcinoma Based on TCM...	Affiliated Hospital of Chengde Medical University	Observational	Not yet recruiting	Liver Cancer	500		clinicaltrials.gov
July 27, 2026	NCT07727759	CT Volumetry and Hepatic Vascular Deformation Mapping to Predict Post-Hepatectomy Liver Failure	Minia University	Observational	Recruiting	Post-Hepatectomy Liver Failure, Liver Failure, Liver Neoplasms, Carcinoma, Hepatocellular, Liver Metastases...	1,070	Egypt	clinicaltrials.gov
July 24, 2026	NCT07726329	Dendritic Cell-immunotherapy for Advanced Hepatocellular Carcinoma	Chang Gung Memorial Hospital	Phase 2	Active not recruiting	Liver Neoplasms	100	Taiwan	clinicaltrials.gov
July 22, 2026	NCT07719933	Intraoperative Continuous Terlipressin Infusion is Associated With Reduced Severe Postoperative Complications After Laparoscopic...	First Affiliated Hospital, Sun Yat-Sen University	Observational	Completed	Liver Neoplasms, Postoperative Complications	161	China	clinicaltrials.gov
July 21, 2026	NCT07717437	DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver...	Maastricht University Medical Center	Observational	Recruiting	Liver Cancer, Liver Metastases	350	Australia, Austria, Belgium, Canada, Germany, Netherlands, New Zealand, Norway...	clinicaltrials.gov
July 20, 2026	NCT07714538	Breath Research Narrow Validation for Gastrointestinal Cancer Detection	Imperial College London	Observational	Recruiting	Oesophageal Squamous Cell Carcinoma, Oesophageal Adenocarcinoma, Gastric Adenocarcinoma, Pancreatic Ductal...	1,000	United Kingdom	clinicaltrials.gov
July 15, 2026	NCT07704203	Preoperative 3D Magnetic Resonance Elastography for Predicting Surgical Risk in Patients Undergoing Hepatectomy	Second Affiliated Hospital of Xi'an Jiaotong University	Observational	Not yet recruiting	Hepatic Cancer, Hepatocellular Carcinoma, Intrahepatic Cholangiocellular Carcinoma, Metastatic Hepatocellular Carcinoma	150		clinicaltrials.gov
July 8, 2026	NCT07690683	Patients With Hepatocellular Carcinoma (HCC)	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	Not applicable	Not yet recruiting	Hepatocellular Carcinoma, Hepatocellular Cancer, Liver Diseases, Liver Cancer	52	Italy	clinicaltrials.gov
July 6, 2026	NCT07685535	HAIC + DEB-TACE + Toripalimab + Lenvatinib for Unresectable Intrahepatic Cholangiocarcinoma	Shanghai Zhongshan Hospital	Phase 2	Not yet recruiting	Liver Cancer	29		clinicaltrials.gov
July 6, 2026	NCT07684040	A Study of Combination Therapy in Patients With Resectable Liver Cancer	Affiliated Hospital of Guangdong Medical University	Phase 2	Not yet recruiting	Liver Cancer (Primary and Metastatic)	68	China	clinicaltrials.gov
June 30, 2026	NCT07676383	Precision Navigation to Improve Community Cancer Screening Participation	Hunan Cancer Hospital	Not applicable	Recruiting	Cancer Screening, Lung Cancer, Breast Cancer, Colorectal Cancer, Upper Gastrointestinal Cancer, Liver Cancer	1,500	China	clinicaltrials.gov
June 30, 2026	NCT07675187	HCC Risk and Monitoring in Patients With Type 2 Diabetes	National Taiwan University Hospital	Not applicable	Not yet recruiting	Type 2 Diabetes (T2DM), Hepatocellular Carcinoma (HCC)	2,400	Taiwan	clinicaltrials.gov
June 22, 2026	NCT07658586	AI Multimodal Model for Liver Cancer Diagnosis and Prognosis	Guangxi Medical University	Observational	Active not recruiting	Liver Cancer, Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma (Icc)	600	China	clinicaltrials.gov
June 18, 2026	NCT07658313	Digitally Supported Prehabilitation Before Major Visceral Cancer Surgery	Ludwig Boltzmann Institute for Digital Health and Prevention	Not applicable	Not yet recruiting	Gastrointestinal Neoplasms, Pancreatic Neoplasms, Liver Neoplasm, Oesophageal Cancer, Gastrointestinal Cancer...	30	Austria	clinicaltrials.gov
June 17, 2026	NCT07653594	TRANScriptional Pathways Of Surgical Pain Modulated by Music Therapy Exposure (TRANSPOSE)	Case Comprehensive Cancer Center	Not applicable	Not yet recruiting	Surgery, Stomach Cancer, Pancreas Cancer, Bile Duct Cancer, Liver Cancer, Peritoneal Cancer	20	United States	clinicaltrials.gov
June 12, 2026	NCT07645209	A Real-world Study of Immunotherapy Combination Regimens for Treating Liver Cancer in Cold Regions	Harbin Medical University	Observational	Active not recruiting	Liver Cancer	1,000	China	clinicaltrials.gov
June 11, 2026	NCT07642336	Erector Spinae Plane Block Versus Thoracic Epidural Analgesia for Open Liver Resection	Nguyen Toan Thang	Not applicable	Completed	Liver Neoplasms, Hepatic Resection, Liver Cancer	60	Vietnam	clinicaltrials.gov
June 9, 2026	NCT07636148	Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance	Mark C Burgmans, MD PhD	Observational	Recruiting	Liver Cancer (Primary and Metastatic), Lung Cancer (Diagnosis), Bone Cancer Metastatic, Bone Cancer Tumor, Kidney...	2,000	France, Netherlands	clinicaltrials.gov
June 5, 2026	NCT07630610	Feasibility and Safety of Augmented Reality (AR) in Liver Tumor Surgery	Navari Surgical AB	Not applicable	Not yet recruiting	Liver Neoplasms	6		clinicaltrials.gov
May 22, 2026	NCT07602504	China Metastatic Liver Cancer Clinical Registry Cohort Database	Anhui Provincial Hospital	Observational	Recruiting	Liver Metastases, Metastases to Liver, Liver Cancer, Neoplasms, Liver Diseases, Colorectal Cancer Metastatic	2,000	China	clinicaltrials.gov
May 22, 2026	NCT07601464	Evaluation of Tissue and Circulating microRNA Profiles in Patients With Hepatocellular Carcinoma Subjected to Thermal Ablation	IRCCS Azienda Ospedaliero-Universitaria di Bologna	Observational	Recruiting	Hepatocarcinoma	150	Italy	clinicaltrials.gov
May 14, 2026	NCT07587216	Prospective Clinical Database Construction for Liver Cancer Diagnosis and Treatment	Tongji Hospital	Observational	Recruiting	Liver Cancer (Primary and Metastatic)	800	China	clinicaltrials.gov
May 14, 2026	NCT07587034	HAIC-TACE Plus Apatinib and Camrelizumab for Liver Cancer	Shanghai Zhongshan Hospital	Phase 1/2	Not yet recruiting	Liver Cancer	315		clinicaltrials.gov
May 14, 2026	NCT07586046	Defining the Ablative Dose for Y-90 TARE	Northwestern University	Phase 2	Recruiting	HCC - Hepatocellular Carcinoma	30	United States	clinicaltrials.gov
May 13, 2026	NCT07583381	A Prospective Study of a Subharmonic-Aided Pressure Estimate Technology for Early Prediction of Response to Systemic Therapy in Colorectal...	The First Hospital of Jilin University	Not applicable	Not yet recruiting	Colorectal Liver Metastasis, Liver Neoplasms, Colorectal Neoplasms	107		clinicaltrials.gov
May 12, 2026	NCT07581730	A Subharmonic-Aided Pressure Estimate Technology for Prediction of Response to Systemic Therapy in Gastric Cancer Liver Metastases	The First Hospital of Jilin University	Observational	Not yet recruiting	Liver Neoplasms, Gastric Cancer (GC), Gastric Cancer Metastatic to Liver	107		clinicaltrials.gov
April 29, 2026	NCT07556835	Outcomes After Liver and Biliary Resection at a High-Volume Center	Azienda USL Toscana Centro	Observational	Not yet recruiting	Liver Neoplasms, Hepatobiliary Diseases, Cholangiocarcinoma, Hepatocellular Carcinoma, Liver Metastases From Colorectal...	1,000	Italy	clinicaltrials.gov
April 17, 2026	NCT07537205	The Effects of a Nurse-led TGA-based Pre-rehabilitation Planning on Perioperative Outcomes in Patients With Liver Cancer: Study and Protocol	Fudan University	Not applicable	Enrolling by invitation	Liver Cancer	92	China	clinicaltrials.gov
April 8, 2026	NCT07517198	Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors	Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.	Phase 1	Recruiting	Solid Tumor, Small Cell Lung Cancer (SCLC), High Grade Neuroendocrine Cancer, Small Cell Carcinomas of Non-lung Origin...	40	United States	clinicaltrials.gov
March 31, 2026	NCT07504367	Large Language Models Assist in Tumor MDT	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	Not applicable	Recruiting	Lung Cancer, Breast Cancer, Colorectal Cancer, Stomach Cancer, Liver Cancer	60	China	clinicaltrials.gov
March 30, 2026	NCT07500220	Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCC	Beijing Biotech	Phase 1/2	Recruiting	Advanced Hepatocellular Carcinoma (HCC), Metastatic Liver Cancer	30	China	clinicaltrials.gov
March 16, 2026	NCT07473687	Feasibility Study of Non-Contact Imaging-Based Physiological Monitoring in the Operating Room	Taipei Veterans General Hospital, Taiwan	Observational	Recruiting	Cholecystitis, Liver Neoplasms, Cholelithiasis, Inguinal Hernia	315	Taiwan	clinicaltrials.gov
March 9, 2026	NCT07459309	Clinical Study on the Safety, Efficacy, and Exploration of Immune Mechanisms of a Combined Multimodal Tumor Therapy System for Hepatic...	Fudan University	Not applicable	Recruiting	Liver Cancer (Primary and Metastatic), Liver Ablation	20	China	clinicaltrials.gov
March 3, 2026	NCT07447050	Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial	University of California, Irvine	Phase 2	Recruiting	Breast Cancer, Sarcoma, Gastric (Stomach) Cancer, Lung Cancer, Head and Neck Cancer, Colorectal Cancer, Ovarian Cancer...	24	United States	clinicaltrials.gov
March 3, 2026	NCT07445412	Italian Group of Regenerative and Occlusive Worldwide-used Techniques of Hepatic Hypertrophy	IRCCS Azienda Ospedaliero-Universitaria di Bologna	Observational	Recruiting	Liver Tumours, Liver Cancer (Primary and Metastatic), Liver Resection, Liver Hypertrophy	2,000	Italy	clinicaltrials.gov
March 3, 2026	NCT07445386	Transdiscal vs Paravertebral Neurolytic Splanchnic Nerve Block for Upper Abdominal Cancer Pain	Ankara Etlik City Hospital	Not applicable	Recruiting	Cancer Pain	56	Turkey (Türkiye)	clinicaltrials.gov
February 27, 2026	NCT07436988	Affordable Made-in-India Microspheres for Liver Cancer Therapy	Post Graduate Institute of Medical Education and Research, Chandigarh	Phase 1	Not yet recruiting	Hepatecellular Carcinoma	18	India	clinicaltrials.gov
February 24, 2026	NCT07430202	A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With...	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Phase 1	Recruiting	Liver Cancer (Fibrolamellar Hepatocellular Cancer (FLC))	27	United States	clinicaltrials.gov
February 17, 2026	NCT07414433	Validation of Blood-Based Biomarkers in TACE-Treated Hepatocellular Carcinoma	University of Belgrade	Observational	Not yet recruiting	Hepatocellular Carcinoma (HCC), Liver Neoplasms	60	Serbia	clinicaltrials.gov
February 17, 2026	NCT07413640	Variability of Microwave Ablation Volume Based on Clinical, Radiological, Biological, and Tissue Factors	Central Hospital, Nancy, France	Observational	Recruiting	Liver Neoplasm	90	France	clinicaltrials.gov
February 13, 2026	NCT07410676	EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors	Essen Biotech	Phase 1/2	Recruiting	Cancer, Sarcoma, Leukaemia, Breast Cancer (Locally Advanced or Metastatic), Lung Cancer (Diagnosis), Colorectal Cancer...	83	China	clinicaltrials.gov
February 13, 2026	NCT07410494	Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors	Essen Biotech	Phase 1/2	Recruiting	Cancer, Breast Cancer, Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (Locally Advanced or Metastatic), Prostate...	85	China	clinicaltrials.gov
February 12, 2026	NCT07407257	SBRT for Liver Tumors, Liver Metastases, and Pancreatic Tumors	Institute of Oncology Ljubljana	Not applicable	Completed	Liver Neoplasms, Liver Metastases, Pancreatic Neoplasms	65	Slovenia	clinicaltrials.gov
February 5, 2026	NCT07390838	A Study of SH009 Injection in Patients With Advanced Solid Tumors.	Nanjing Sanhome Pharmaceutical, Co., Ltd.	Phase 1	Recruiting	Liver Cancer (Locally Advanced or Metastatic), Lung Cancer (NSCLC), Head and Neck Cancer Squamous Cell Carcinoma...	150	China	clinicaltrials.gov
February 4, 2026	NCT07386639	Sex-Specific Machine Learning Models to Predict Distant Metastasis in Liver Cancer	Tongji University	Observational	Completed	Hepatocellular Carcinoma, Liver Cancer, Neoplasm Metastasis	19,019		clinicaltrials.gov
January 30, 2026	NCT07378709	Exploratory Blood-Based Biomarkers in TACE-Treated Hepatocellular Carcinoma	University of Belgrade	Observational	Recruiting	Hepatocellular Carcinoma (HCC), Liver Neoplasms	15	Serbia	clinicaltrials.gov
January 30, 2026	NCT07377487	TheraSphere Japan Pre-Market Study	Boston Scientific Corporation	Not applicable	Recruiting	Liver Neoplasms	51	Japan	clinicaltrials.gov
January 23, 2026	NCT07362264	A Study of SH006 Injection Combination Therapy in Patients With Advanced Solid Tumors	Nanjing Sanhome Pharmaceutical, Co., Ltd.	Phase 1	Active not recruiting	Liver Cancer	50	China	clinicaltrials.gov
January 21, 2026	NCT07356531	Clinical Trial Evaluating the Safety and Efficacy of Tumor Thermosensitive Embolic Agent in Transcatheter Arterial Chemoembolization for...	JIANGSU SHENMING Medical Technology CO., Ltd	Not applicable	Recruiting	Liver Cancer	216	China	clinicaltrials.gov
January 16, 2026	NCT07346573	Radiotherapy Safety for Liver Malignancies Using Post-Treatment Imaging	Cao peiguo	Observational	Completed	Liver Neoplasms, Radiation-Induced Liver Injury	274	China	clinicaltrials.gov
January 15, 2026	NCT07345247	RAdiation SEgmentectomy With REsin Microspheres (RASEREM) Study	Ankara University	Observational	Recruiting	Liver Cancer, Adult	150	Turkey (Türkiye)	clinicaltrials.gov
January 14, 2026	NCT07341737	SL-28 for Advanced Solid Tumours	Second Life Therapeutics	Phase 1/2	Recruiting	Head & Neck Cancer, Pancreas Carcinoma, Pancreas Cancer, Metastatic, Lung Adenocarcinoma, Lung Cancer (NSCLC), Lung...	60	Australia	clinicaltrials.gov
January 13, 2026	NCT07337525	A First in Human Study of PLT012 in Participants With Solid Tumor Cancers	Pilatus Biosciences Inc	Phase 1	Recruiting	Advanced Malignant Solid Tumor, Solid Tumor Cancer	36	United States	clinicaltrials.gov
January 13, 2026	NCT07337330	Ultrasound Guided External Oblique Intercostal Plane Block Versus Erector Spinae Block for Post Hepatectomy Pain	National Cancer Institute, Egypt	Not applicable	Not yet recruiting	Pain; Cancer, Hepatectomy, Nerve Block	52	Egypt	clinicaltrials.gov
January 12, 2026	NCT07335042	Prediction Model for MINS After Major Hepatobiliary Surgery	Beijing Tsinghua Chang Gung Hospital	Observational	Recruiting	Myocardial Injury After Noncardiac Surgery (MINS), Postoperative Complications, Liver Neoplasm, Hepatobiliary Diseases	1,800	China	clinicaltrials.gov
January 8, 2026	NCT07327489	Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)	Elephas	Observational	Recruiting	Cancer, Immunotherapy, Advanced Solid Tumors Cancer, Bladder Cancer, TNBC, Triple Negative Breast Cancer, Colorectal...	2,000	United States	clinicaltrials.gov
January 8, 2026	NCT07325565	Impact of Emotional Disorders on Response to Immune Checkpoint Inhibitor Therapy in Liver Cancer	Tongji Hospital	Observational	Recruiting	Liver Cancer, Emotional Disorder	651	China	clinicaltrials.gov
January 7, 2026	NCT07321613	Effect of TCC Cocktail Combined With TACE Versus TACE Alone on Survival in uHCC Patients	Shanghai Zhongshan Hospital	Observational	Completed	Hepatocellular Cancer (HCC)	545	China	clinicaltrials.gov
January 5, 2026	NCT07318051	Sample Collection for Ongoing Research and Product Evaluation Study	Natera, Inc.	Observational	Recruiting	Breast Cancer, Lung Cancer, Muscle Invasive Bladder Cancer, Rectal Cancer, Pancreatic Cancer, Ovarian Cancer...	9,600	United States	clinicaltrials.gov
January 5, 2026	NCT07317505	A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors	Conjupro Biotherapeutics, Inc.	Phase 1	Recruiting	Cancer, Cancer (Solid Tumors)	270	United States	clinicaltrials.gov
January 2, 2026	NCT07315633	An Innovative CFD-based Dosimetry and Pre-treatment Planning Platform to Support Personalized Transarterial Therapies for Liver Cancer	University Hospital, Ghent	Observational	Recruiting	Hepatocellular Carcinoma (HCC), Liver Cancer, Adult, Liver Cancer	80	Belgium	clinicaltrials.gov
December 31, 2025	NCT07312292	Radioembolization With Intra-arterial Angiotensin II to Improve Tumor-absorbed Dose (RADIANT)	Niek Wijnen	Phase 2	Recruiting	Liver Cancer (Locally Advanced or Metastatic), Liver Cancer Adult	15	Netherlands	clinicaltrials.gov
December 26, 2025	NCT07303725	Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology	Palo Alto Veterans Institute for Research	Observational	Recruiting	Liver Cancer (Primary and Metastatic), Renal Cancer	30	United States	clinicaltrials.gov
December 22, 2025	NCT07297615	3D Liver Volumetry	Medical University of Graz	Not applicable	Not yet recruiting	Liver Surgery, Liver Cancer, Surgical Planning, Liver, Volumetric Analysis, 3D-reconstruction	25	Austria	clinicaltrials.gov
December 19, 2025	NCT07295340	Diagnostic Accuracy of Folate-Targeted NIR-II Carbon Dots for Ex Vivo HCC Detection	West China Hospital	Observational	Recruiting	Liver Cancer	20	China	clinicaltrials.gov
December 19, 2025	NCT07295275	Safety and Efficacy of Transarterial ICG Fluorescence-Guided Laparoscopic Anatomical Liver Resection	West China Hospital	Observational	Recruiting	Liver Cancer	200	China	clinicaltrials.gov
December 19, 2025	NCT07295262	NIR-II Fluorescence-Guided Hepatectomy Using ICG-Cisplatin Nanoprobes for HCC	West China Hospital	Early phase 1	Recruiting	Liver Cancer, Adult	30	China	clinicaltrials.gov
December 5, 2025	NCT07265544	Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease	Nanfang Hospital, Southern Medical University	Observational	Recruiting	Liver Neoplasm, HBV Infection, Non-alcoholic Fatty Liver Disease NAFLD, Liver Fibrosis	240	China	clinicaltrials.gov
December 4, 2025	NCT07265271	Project for Multi-Omics-Based Early Detection of Hepatocellular Carcinoma (PROMETHEA Study)	City of Hope Medical Center	Observational	Recruiting	Hepatocellular Carcinoma (HCC)	600	United States	clinicaltrials.gov
December 2, 2025	NCT07260058	Immune Cell Therapy for Advanced Solid Tumors	Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.	Phase 1/2	Not yet recruiting	Lung Cancer (Locally Advanced or Metastatic), Liver Cancer (Locally Advanced or Metastatic), Colorectal Cancer (Locally...	48		clinicaltrials.gov
November 24, 2025	NCT07246668	A Phase II Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Carbon Ion Radiotherapy With Atezolizumab and Bevacizumab...	Yonsei University	Phase 2	Recruiting	Hepatocellular Carcinoma, Liver Neoplasms, Carcinoma, Hepatocellular	52	South Korea	clinicaltrials.gov
November 24, 2025	NCT07243951	Phase II Clinical Study on the Efficacy and Safety of the Combination of Cadonilimab and Capecitabine in Adjuvant Therapy for Combined...	Shanghai Zhongshan Hospital	Phase 2	Not yet recruiting	Combined Hepatocellular-cholangiocarcinoma, Liver Neoplasms	75		clinicaltrials.gov
November 18, 2025	NCT07233759	The Study Collect Clinical Data From the Treatment of Liver Cancer With New Drugs After 2019 and Integrate Biochemical and Pathological...	National Taiwan University Hospital	Observational	Active not recruiting	Liver Cancer, Pembrolizumab, Atezolizumab, Lenvatinib	2,500	Taiwan	clinicaltrials.gov
November 12, 2025	NCT07227012	Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult...	Pfizer	Phase 1/2	Recruiting	Carcinoma, Hepatocellular, Hepatocellular Cancer, Hepatocellular Carcinoma, Unresectable Hepatocellular Carcinoma...	138	China, Japan, Puerto Rico, Taiwan, United States	clinicaltrials.gov
November 12, 2025	NCT07226869	Computer Guided Microwave Liver Ablation	NE Scientific INC	Not applicable	Recruiting	Hepatocellular Carcinoma (HCC)	84	United States	clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
Shanghai Zhongshan Hospital	7	November 5, 2026
West China Hospital	6	August 13, 2026
Anhui Provincial Hospital	4	September 21, 2026
National Taiwan University Hospital	4	June 30, 2026
IRCCS Azienda Ospedaliero-Universitaria di Bologna	3	May 22, 2026
Tongji Hospital	3	May 14, 2026
Fudan University	3	April 17, 2026
City of Hope Medical Center	3	December 4, 2025
UNC Lineberger Comprehensive Cancer Center	2	November 4, 2026
BeOne Medicines	2	November 3, 2026
Assiut University	2	October 29, 2026
Varian, a Siemens Healthineers Company	2	October 28, 2026
Fondazione Policlinico Universitario Agostino Gemelli IRCCS	2	September 22, 2026
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	2	August 28, 2026
Imperial College London	2	July 20, 2026
Case Comprehensive Cancer Center	2	June 17, 2026
The First Hospital of Jilin University	2	May 13, 2026
University of Belgrade	2	February 17, 2026
Essen Biotech	2	February 13, 2026
Nanjing Sanhome Pharmaceutical, Co., Ltd.	2	February 5, 2026

By phase

Phase	New trials	Latest
Observational	76	November 2, 2026
Not applicable	42	November 4, 2026
Phase 2	21	November 5, 2026
Phase 1	16	August 13, 2026
Phase 1/2	11	May 14, 2026
Early phase 1	3	August 24, 2026
Phase 3	1	September 23, 2026
Phase 4	1	August 27, 2026
Phase 2/3	1	February 28, 2025

By country

Country	New trials	Latest
China	60	November 5, 2026
United States	44	November 4, 2026
Taiwan	10	July 24, 2026
Italy	8	September 22, 2026
South Korea	6	November 2, 2026
France	5	June 9, 2026
Spain	4	July 21, 2026
United Kingdom	4	July 21, 2026
Egypt	3	October 29, 2026
Australia	3	July 21, 2026
Austria	3	July 21, 2026
Netherlands	3	July 21, 2026
Turkey (Türkiye)	3	March 3, 2026
Japan	3	January 30, 2026
Israel	3	March 5, 2025
Germany	2	September 10, 2026
Belgium	2	July 21, 2026
Canada	2	July 21, 2026
Serbia	2	February 17, 2026
Puerto Rico	2	November 12, 2025
New Zealand	1	July 21, 2026
Norway	1	July 21, 2026
Sweden	1	July 21, 2026
Switzerland	1	July 21, 2026
Vietnam	1	June 11, 2026

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.